Replies to post #39817 on Avid Bioservices Inc (CDMO)

[cjgaddy]

Interesting, ‘New-Scientist’ chgd. the title of 8-5-09 Bob Holmes article that highlighted BaviAV/Thorpe/Peregrine from “Could One Drug Kill All Germs?” to “How To Cure Diseases Before They Have Even Evolved”…

http://www.newscientist.com/article/mg20327200.100-could-one-drug-kill-all-germs.html?full=true
:
V
http://www.newscientist.com/article/mg20327200.100-how-to-cure-diseases-before-they-have-even-evolved.html?full=true

= = = = = = = = FROM ONE OF DR. THORPE’S ANTI-LIPID PATENT APPS:
[0919] “The therapeutics provided by the invention are valuable agents having broad-spectrum anti-viral activity. In addition to being effective against a large number of potentially lethal viruses, the agents an also be administered after exposure to the virus, even in settings where the exact nature of the virus is not known. Thus, the anti-viral therapeutics of the present invention do not require a prolonged period of time between identification of the pathogen and delivery of the therapy, in marked contrast with the time and expense entailed by the development, production or delivery of specific vaccines.”
#20040161429 (pub. USPO 8-19-04): “Compositions for treating Viral Infections using Immunoconjugates to Aminophospholipids”
http://tinyurl.com/6pdny

= = = = = = = = =
“New Scientist is a science magazine for everyone, young and old, amateur and professional. With a circulation approaching 160,000 and a worldwide readership of more than half a million, it is among the most popular of all popular science magazines.”
http://authors.simonandschuster.com/New-Scientist/38174292/biography